InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the detailed record of transactions filed by Hunt Hazel, Directeur Scientifique. Officer active across 2 companies, notably Corcept Therapeutics INC. In total, 9 filings have been published. Breakdown: 0 buy · 1 sell. Total volume traded: €579k. Activity tracked since 14 July 2021. The latest transaction was filed on 9 February 2026 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Hunt Hazel
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations9 total
150,000 shares@ US$3.8821.1% of flowCommon StockSEC:0001193125-26-046881:0
150,000 shares@ US$3.2926.1% of flowCommon StockSEC:0000950170-25-020219:0
60,000 shares@ US$2.818.5% of flowCommon StockSEC:0000950170-24-091049:0
50,000 shares@ US$3.027.5% of flowCommon StockSEC:0000950170-24-004343:0
20,455 shares@ US$30.88531.5% of flowCommon StockSEC:0000950170-23-042785:0
50,000 shares@ US$3.027.5% of flowCommon StockSEC:0000950170-23-040803:0
50,000 shares@ US$2.085.8% of flowCommon StockSEC:0000899243-22-032305:0
40,000 shares@ US$3.325.0% of flowCommon StockSEC:0000899243-22-003573:0
50,000 shares@ US$2.895.2% of flowCommon StockSEC:0000899243-21-028678:0
9 of 9 declarations
About Hunt Hazel
Hunt Hazel is Directeur Scientifique and Chief Scientific Officer at CORCEPT THERAPEUTICS INC, listed on XNAS. She has filed 9 forms in total, and across the recent filings observed from 2021-07-16 to 2026-02-11, the amounts show EUR 0 of buys and EUR 579065 of sells, with Levée d'options as the most frequent transaction type.
